Role of Atypical Antipsychotics in the Treatment of Generalized Anxiety Disorder

Aripiprazole as Augmentation Treatment of Refractory Generalized Anxiety Disorder and Panic Disorder

(2016) Elizabeth A. Hoge et al.   CNS SPECTRUMS

Atypical Antipsychotic Augmentation Strategies in the Context of Guideline-based Care for the Treatment of Major Depressive Disorder

(2013) Ashwin A. Patkar et al.   CNS DRUGS

Antipsychotic-Induced Insulin Resistance and Postprandial Hormonal Dysregulation Independent of Weight Gain or Psychiatric Disease

(2013) Karen L. Teff et al.   DIABETES

New approaches to the pharmacological management of generalized anxiety disorder

(2013) Massimiliano Buoli et al.   EXPERT OPINION ON PHARMACOTHERAPY

Prevalence and features of generalized anxiety disorder in Department of Veteran Affairs primary care settings

(2013) Melissa E. Milanak et al.   PSYCHIATRY RESEARCH

Tolerability and use in co-administration of pregabalin in affective patients: a 6-month prospective naturalistic study

(2012) Cristina Dobrea et al.   Expert Opinion On Drug Safety

Double-blind, randomized study of extended release quetiapine fumarate (quetiapine XR) monotherapy in older patients with generalized anxiety disorder

(2012) Irina Mezhebovsky et al.   INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY

Guidelines for the pharmacological treatment of anxiety disorders, obsessive–compulsive disorder and posttraumatic stress disorder in primary care

(2012) Borwin Bandelow et al.   INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE

Open, Aware, and Active: Contextual Approaches as an Emerging Trend in the Behavioral and Cognitive Therapies

(2011) Steven C. Hayes et al.   Annual Review of Clinical Psychology

Second generation antipsychotics (SGAs) for non-psychotic disorders in children and adolescents: A review of the randomized controlled studies

(2011) Alessandro Zuddas et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Pharmacological treatment of generalized anxiety disorder

(2011) Jennifer A Reinhold et al.   EXPERT OPINION ON PHARMACOTHERAPY

Augmentative quetiapine in partial/nonresponders with generalized anxiety disorder

(2011) Alfredo Carlo Altamura et al.   INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

Efficacy and tolerability of extended release quetiapine fumarate monotherapy in the acute treatment of generalized anxiety disorder

(2011) Charles Merideth et al.   INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

Efficacy and Comparative Effectiveness of Atypical Antipsychotic Medications for Off-Label Uses in Adults

(2011) Alicia Ruelaz Maher et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

A Randomized, Double-Blind Study of Once-Daily Extended Release Quetiapine Fumarate (Quetiapine XR) Monotherapy in Patients With Generalized Anxiety Disorder

(2011) Arifulla Khan et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Aripiprazole in schizophrenia and schizoaffective disorder: A review

(2010) Emmanuel Stip et al.   CLINICAL THERAPEUTICS

Extended release quetiapine fumarate (quetiapine XR) monotherapy as maintenance treatment for generalized anxiety disorder

(2010) Martin A. Katzman et al.   INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

Number Needed to Treat to Harm for Discontinuation Due to Adverse Events in the Treatment of Bipolar Depression, Major Depressive Disorder, and Generalized Anxiety Disorder With Atypical Antipsychotics

(2010) Keming Gao et al.   JOURNAL OF CLINICAL PSYCHIATRY

Ziprasidone Treatment of Refractory Generalized Anxiety Disorder

(2010) Falk W. Lohoff et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Adjunctive Use of Atypical Antipsychotics for Treatment-Resistant Generalized Anxiety Disorder

(2010) Raymond A Lorenz et al.   PHARMACOTHERAPY

Current Considerations in the Treatment of Generalized Anxiety Disorder

(2009) Martin A. Katzman   CNS DRUGS

Serotonin norepinephrine reuptake inhibitors (SNRIs) in anxiety disorders: a comprehensive review of their clinical efficacy

(2009) Bernardo Dell'Osso et al.   HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL

Extended-release quetiapine fumarate (quetiapine XR): a once-daily monotherapy effective in generalized anxiety disorder. Data from a randomized, double-blind, placebo- and active-controlled study

(2009) Borwin Bandelow et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

A Placebo-Controlled, Fixed-Dose Study of Aripiprazole in Children and Adolescents With Irritability Associated With Autistic Disorder

(2009) Ronald N. Marcus et al.   JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY

Atypical Antipsychotic Drugs and the Risk of Sudden Cardiac Death

(2009) Wayne A. Ray et al.   NEW ENGLAND JOURNAL OF MEDICINE

Generalized Anxiety Disorder, Major Depressive Disorder, and Their Comorbidity as Predictors of All-Cause and Cardiovascular Mortality: The Vietnam Experience Study

(2009) Anna C. Phillips et al.   PSYCHOSOMATIC MEDICINE

Quetiapine augmentation of paroxetine CR for the treatment of refractory generalized anxiety disorder: preliminary findings

(2008) Naomi M. Simon et al.   PSYCHOPHARMACOLOGY